Viewing Study NCT02276560


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-02-25 @ 8:11 PM
Study NCT ID: NCT02276560
Status: TERMINATED
Last Update Posted: 2017-05-11
First Post: 2014-10-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage IIIA Non-Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None main tumor ranging from less than 3cm (T1 up to … View